In a constituent update released today, the US FDA discuses a letter that has been issued to the powdered infant formula industry to share safety information and to call on the industry to take prompt action to improve processes and programs to protect the most vulnerable population. The update also describes steps the FDA has taken to improve the resiliency of infant formula supply, steps to enhance safety of powdered infant formula, and other actions the FDA has taken and continues to take to ensure safety of infant formula in the US market. The update also mentions congressional requirements recently added to mitigate supply chain disruptions.
Posted March 8, 2023